Synthetic B-Cell epitopes eliciting cross-neutralizing antibodies: Strategies for future dengue vaccine

QR Code

Synthetic B-Cell epitopes eliciting cross-neutralizing antibodies: Strategies for future dengue vaccine

Dengue virus (DENV) is a major public health threat worldwide. A key element in protection from dengue fever is the neutralising antibody response. Anti-dengue IgG purified from DENV-2 infected human sera showed reactivity against several peptides when evaluated by ELISA and epitope extraction techn...

Full description

Bibliographic Details
Main Authors:	Ramanathan, Babu , Poh, Chit Laa , Kirk, Kristin, McBride, William John Hannan, Aaskov, John, Grollo, Lara
Format:	Article
Language:	English
Published:	PLOS 2016
Subjects:	QR Microbiology R Medicine (General)
Online Access:	http://eprints.sunway.edu.my/454/ http://eprints.sunway.edu.my/454/1/Ramanathan%202016%20Synthetic%20B.pdf

Similar Items

Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach
by: Kirk, Kristin, et al.
Published: (2012)

Enterovirus specific anti-peptide antibodies
by: Poh, Chit Laa *, et al.
Published: (2015)

Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting
by: Lim, Hui Xuan *, et al.
Published: (2022)

Enhancement of tetravalent immune responses to highly conserved epitopes of a dengue peptide vaccine conjugated to polystyrene nanoparticles
by: Chan, Yanqi, et al.
Published: (2020)

Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine
by: Lim, Hui Xuan *, et al.
Published: (2021)

Structure-based design of antivirals against Envelope Glycoprotein of dengue virus
by: Anasir, M. I. *, et al.
Published: (2020)

Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)

In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
by: Pourianfar, Hamid Reza, et al.
Published: (2012)

The Regulation of Peptide Mimotope/Epitope Recognition by Monoclonal Antibodies
by: Smith, Richard Gary
Published: (2002)

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitus C virus E2 protein confer noninterfering, additive neutralization
by: Tarr, Alexander W., et al.
Published: (2012)

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the Hepatitis C virus E2 protein confer noninterfering, additive neutralization
by: Tarr, Alexander, W., et al.
Published: (2012)

Investigation of the epitope specificities of antibodies to islet β-cell autoantigens
by: Al-bukhari, Talat Abdullah
Published: (2001)

Epitope mapping of Anti-YB-1 antibodies using truncated proteins
by: Wei, T.C., et al.
Published: (2014)

Development of dengue vaccines
by: Lim, Chee Siean *, et al.
Published: (2018)

The conserved molecular determinants of virulence in dengue virus
by: Zuleeza A,, et al.
Published: (2019)

Development of multi-epitope peptide-based vaccines against SARS-CoV-2
by: Lim, Hui Xuan *, et al.
Published: (2020)

Structural biology of antibody recognition of carbohydrate epitopes and potential uses for targeted cancer immunotherapies
by: Dingjan, T., et al.
Published: (2014)

A phosphorylation-induced turn defines the Alzheimer's disease AT8 antibody epitope on the tau protein
by: Gandhi, Neha, et al.
Published: (2015)

Development of peptide vaccines in dengue
by: Reginald, Kavita*, et al.
Published: (2017)

Climate change and dengue: A critical and systematic review of quantitative modelling approaches
by: Naish, S., et al.
Published: (2014)

Synthetic antibody: prospects in aquaculture biosecurity
by: Chong, Chou Min, et al.
Published: (2019)

Economic Evaluation And Willingness To Pay (Wtp) Elicitation Of Dengue Vaccine In Malaysia
by: Yeo, Hui Yee
Published: (2017)

Peptides as therapeutic agents for dengue virus
by: Chew, Miaw Fang *, et al.
Published: (2017)

Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Spatial and temporal patterns of locally-acquired dengue transmission in Northern Queensland, Australia, 1993-2012
by: Naish, S., et al.
Published: (2014)

Rapid characterization of protein epitopes recognized by monoclonal antibodies using direct probing on thin-layer and paper chromatograms
by: Dowse, Carol, et al.
Published: (1987)

Characterization of a unique conformational epitope on free immunoglobulin kappa light chains that is recognized by an antibody with therapeutic potential
by: Hutchinson, A., et al.
Published: (2011)

Molecular Mechanisms of Antiviral Agents against Dengue Virus
by: Lee, Michelle Felicia, et al.
Published: (2023)

Mapping Of Nucleocapsid Protein (Np) Epitopes and Np-Phosphoprotein Interactive Domains of Newcastle Disease Virus with Np Monoclonal Antibodies
by: Ahmad Raus, Raha
Published: (2006)

Development of novel antiviral peptides against dengue serotypes 1-4
by: Lee, Michelle Felicia, et al.
Published: (2023)

Role of microRNAs in antiviral responses to dengue infection
by: Wong, Rui Rui, et al.
Published: (2020)

Biofunctionalized tapered multimode fiber for dengue virus antibody detection
by: Mustapa, Mohd Azmir
Published: (2017)

Development of single chain variable fragment antibodies against dengue virus
by: Leong, Yee Wei.
Published: (2006)

Innate and adaptive immune evasion by dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Current methods for the prediction of T-cell epitopes
by: Kar, Prattusha, et al.
Published: (2018)

Reply to 'response to Milland et al.: Carbohydrate residues downstream of the terminal gala(1,3)gal epitope modulate the specificity of xenoreactive antibodies'
by: Milland, J., et al.
Published: (2008)

An investigation into interest and its elicitation in Middle School Science lessons
by: Newton-John, Osmar Jeremy
Published: (2015)

SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade
by: Xue, Wei, et al.
Published: (2016)

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
by: Desombere, Isabelle, et al.
Published: (2017)

Elucidation of the monoclonal antibody 5G8-reactive, virulence-associated lipopolysaccharide epitope of haemophilus influenzae and its role in bacterial resistance to complement-mediated killing
by: Griffin, R., et al.
Published: (2005)